Allergenis
Company profile on P2PMarketData. Allergenis is a biotechnology company based in New York, NY, founded in 2017. It has raised $560.6K through crowdfunding on StartEngine.
Allergenis is a biotechnology company founded in 2017 and headquartered in New York, NY, United States. The company provides food allergy testing using systems biology and data analytics to determine allergic status, tolerance levels, and reaction severity. Allergenis' test can be initiated through a telemedicine channel, allowing individuals to receive medical support from an allergist.
Frequently asked questions about Allergenis
How much funding has Allergenis raised?
Allergenis has raised $560.6K through crowdfunding across 1 round tracked by P2PMarketData, from 267 investors.
What is Allergenis' valuation?
Allergenis had an indicative valuation of $40M in its 2023 funding round.
What is Allergenis' revenue?
Allergenis reported revenue of $486K for fiscal year 2023.
Is Allergenis profitable?
No. Allergenis reported a net loss of $2.7M for fiscal year 2023.
How many employees does Allergenis have?
Allergenis reported 3 employees for fiscal year 2023.
When was Allergenis founded?
Allergenis was founded in September 2017.
Where is Allergenis based?
Allergenis is headquartered in New York, New York, United States, and is incorporated in Delaware, United States.
What industry is Allergenis in?
Allergenis operates in the Biotechnology industry within the Healthcare sector.